Champions Oncology Inc (CSBR)
4.70
-0.03
(-0.63%)
USD |
NASDAQ |
May 17, 16:00
Champions Oncology Total Liabilities (Quarterly): 28.84M for Jan. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 28.84M |
October 31, 2023 | 28.20M |
July 31, 2023 | 28.00M |
April 30, 2023 | 29.68M |
January 31, 2023 | 29.09M |
October 31, 2022 | 27.19M |
July 31, 2022 | 25.41M |
April 30, 2022 | 26.28M |
January 31, 2022 | 24.35M |
October 31, 2021 | 21.22M |
July 31, 2021 | 20.57M |
April 30, 2021 | 20.16M |
January 31, 2021 | 17.39M |
October 31, 2020 | 18.87M |
July 31, 2020 | 17.31M |
April 30, 2020 | 15.65M |
January 31, 2020 | 11.90M |
October 31, 2019 | 11.83M |
July 31, 2019 | 11.63M |
April 30, 2019 | 9.027M |
January 31, 2019 | 8.588M |
October 31, 2018 | 8.247M |
July 31, 2018 | 7.789M |
April 30, 2018 | 8.075M |
January 31, 2018 | 6.623M |
Date | Value |
---|---|
October 31, 2017 | 6.12M |
July 31, 2017 | 6.177M |
April 30, 2017 | 7.611M |
January 31, 2017 | 5.506M |
October 31, 2016 | 4.839M |
July 31, 2016 | 4.673M |
April 30, 2016 | 5.539M |
January 31, 2016 | 4.886M |
October 31, 2015 | 3.48M |
July 31, 2015 | 3.945M |
April 30, 2015 | 3.988M |
January 31, 2015 | 6.977M |
October 31, 2014 | 5.169M |
July 31, 2014 | 5.239M |
April 30, 2014 | 5.67M |
January 31, 2014 | 5.985M |
October 31, 2013 | 6.363M |
July 31, 2013 | 4.683M |
April 30, 2013 | 3.975M |
January 31, 2013 | 3.677M |
October 31, 2012 | 11.41M |
July 31, 2012 | 10.98M |
April 30, 2012 | 4.041M |
January 31, 2012 | 12.24M |
October 31, 2011 | 12.26M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.63M
Minimum
Jul 2019
29.68M
Maximum
Apr 2023
21.77M
Average
21.22M
Median
Oct 2021
Total Liabilities (Quarterly) Benchmarks
AIM ImmunoTech Inc | 9.147M |
Perspective Therapeutics Inc | 48.40M |
Protalix BioTherapeutics Inc | 60.04M |
Electromed Inc | 6.357M |
Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 26.79M |
Shareholders Equity (Quarterly) | -2.058M |
Current Ratio | 0.6008 |